Pharmacokinetics and bioavailability of itraconazole oral solution in cats
Authors:
- 27 April 2015
- journal article
- research article
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 18 (4) , 310-314
Abstract
Objectives: The aim of this study was to describe the pharmacokinetics and bioavailability of itraconazole (ITR) oral solution in healthy cats. Methods: The pharmacokinetics of ITR were studied in eight healthy, fasted cats after a single intravenous (IV) and oral (PO) administration at a dose of 5 mg/kg, in a two-period crossover design study. Blood was obtained at predetermined intervals for the determination of ITR concentrations with high-performance liquid chromatography. Pharmacokinetic characterisation was performed by a non-compartmental method using WinNonlin 5.2.1. Results: After IV administration, the major pharmacokinetic parameters were as follows (mean ± SD): terminal elimination half-life (T 1/2λz ) 15.8 ± 1.88 h; area under the curve from time zero to infinity (AUC 0– ∞ ) 13.9 ± 3.17 h·μg/ml; total body clearance 0.37 ± 0.08 l/h/kg; apparent volume of distribution 8.51 ± 1.92 l/kg; mean residence time 20.6 ± 3.95 h. After PO administration, the principal pharmacokinetic parameters were as follows (mean ± SD): T 1/2λz 15.6 ± 3.20 h; AUC 0– ∞ 7.94 ± 2.83 h·μg/ml; peak concentration 0.70 ± 0.14 μg/ml; time of peak 1.43 ± 0.53 h. The absolute bioavailability of ITR oral solution after oral administration was 52.1 ± 11.6%. Conclusions and relevance: The disposition of ITR oral solution in cats is characterised by a long terminal half-life, a short peak time and moderate bioavailability.Keywords
This publication has 21 references indexed in Scilit:
- Bioequivalence of Orally Administered Generic, Compounded, and Innovator-Formulated Itraconazole in Healthy DogsJournal of Veterinary Internal Medicine, 2014
- Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infectionsExpert Opinion on Drug Metabolism & Toxicology, 2013
- Pharmacokinetics of Itraconazole in Diabetic RatsAntimicrobial Agents and Chemotherapy, 2010
- Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with β-cyclodextrin using supercritical carbon dioxideJournal of Pharmaceutical and Biomedical Analysis, 2007
- Single-Dose Pharmacokinetics of Intravenous Itraconazole and Hydroxypropyl-β-Cyclodextrin in Infants, Children, and AdolescentsAntimicrobial Agents and Chemotherapy, 2007
- Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the ratInternational Journal of Pharmaceutics, 2007
- Pharmacokinetics of Itraconazole Oral Solution in Neutropenic Children during Long-Term ProphylaxisAntimicrobial Agents and Chemotherapy, 2001
- ItraconazoleDrugs, 1996
- Antifungal agents: An overview. Part IIJournal of the American Academy of Dermatology, 1994
- Advances in veterinary mycologyMedical Mycology, 1994